Qulipta 60 mg – DIN 02533995
Qulipta is Atogepant 60 mg (tablet), sold in Canada. It is used for migraine. It is supplied by Abbvie Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Atogepant 60 mg
- Brand
- Qulipta
- Strength
- 60 mg
- Used for
- Migraine
- Form
- Tablet
- Manufacturer
- Abbvie Corporation
- Drug class
- Calcitonin gene-related peptide receptor antagonist
- Sold in
- Canada
- DIN
- 02533995
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Atogepant used for?
Atogepant is used for migraine.
- Medicine type
- Calcitonin gene-related peptide receptor antagonist
Official uses from the US prescribing label
QULIPTA is indicated for the preventive treatment of migraine in adults.
From the FDA-approved label on DailyMed (published Feb 10, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02533995.
- It names Qulipta, Atogepant 60 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Qulipta by Abbvie Corporation.
In Canada: prescription only.
Ingredients
Active: Atogepant
Other Atogepant pills
- A 10 Atogepant 10 mg White, round, 6 mm Used for migraine
- A30 Atogepant 30 mg White, oval, 7 mm Used for migraine
- A60 Atogepant 60 mg White, oval, 9 mm Used for migraine
- No picture yet DIN 02533979 Atogepant 10 mg Qulipta, Tablet, sold in Canada Used for migraine
- No picture yet DIN 02533987 Atogepant 30 mg Qulipta, Tablet, sold in Canada Used for migraine